フィブリンシーラント市場：製品別、エンドユーザー別-2025-2030年の世界予測

フィブリンシーラント市場は、2023年に3億9,116万米ドルと評価され、2024年には4億4,589万米ドルに達すると予測され、CAGR 14.08%で成長し、2030年には9億8,402万米ドルに達すると予測されています。

フィブリンシーラントは、主にフィブリノゲンとトロンビンで構成され、外科手術中の出血を抑え、組織の密封を助ける止血剤として使用されます。フィブリンシーラントの使用範囲は、心臓血管、整形外科、神経外科など様々な診療科に及び、創傷治癒を促進し、術後の合併症を軽減します。これらのシーラントは、縫合や焼灼といった従来の止血方法では不十分な場合に極めて重要であり、複雑な手術ではその応用が不可欠です。最終用途は、病院や外来手術センターから専門クリニックまで幅広いです。フィブリンシーラント市場を牽引する成長要因としては、世界の手術の増加、手術手技の進歩、効果的な出血コントロールを必要とする低侵襲手術への需要の高まりなどが挙げられます。また、手術に伴うリスクの軽減が重視されるようになり、効果的な止血剤の需要が高まっています。この市場開拓のチャンスは、タンパク質の純度と生体適合性を高めた費用対効果の高いシーラントの開発にあり、既存市場と新興市場の両方に対応しています。さらに、特定の外科手術のニーズに合わせた製剤や、スプレーや新しいアプリケーターのデザインなど、革新的な送達システムの展開は、潜在的な成長の道を提供します。しかし、主にフィブリンシーラントのコストが高いこと、副作用や周期的な免疫原性反応の可能性があることなどから、限界は依然として残っています。また、血漿由来成分によるウイルス感染のリスクと並んで、各地域の厳しい規制状況も課題となっています。成長を促進するためには、合成フィブリン製剤または遺伝子組換えフィブリン製剤の開発に重点を置いた研究への投資が有望であり、特にドナー由来製剤への依存を減らすことを目的とした研究への投資は、ウイルスリスクを軽減することができます。市場の競争は激しいが、技術革新の機は熟しており、バイオテクノロジー企業と外科チームの継続的な研究と協力は、新規開発を推進し、市場開拓を拡大する上で極めて重要です。

市場力学：急速に進化するフィブリンシーラント市場の主要市場インサイトを公開

フィブリンシーラント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • マイクロサージャリー処置およびインプラント部位周囲のフラップ閉鎖における使用の増加
  • 歯周創傷治癒と再生を刺激する歯周外科用の代替バイオマテリアル
  • 歯科手術に対する需要の高まり
• 市場抑制要因
  • フィブリンシーラントの高コスト
• 市場機会
  • 政府予算の増加とヘルスケアの質の向上
  • 外科手術の増加に対応する技術の進歩
• 市場の課題
  • アレルギー反応の兆候

ポーターの5つの力：フィブリンシーラント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：フィブリンシーラント市場における外部からの影響の把握

外部マクロ環境要因は、フィブリンシーラント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析フィブリンシーラント市場における競合情勢の把握

フィブリンシーラント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスフィブリンシーラント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、フィブリンシーラント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨フィブリンシーラント市場における成功への道筋を描く

フィブリンシーラント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • マイクロサージェリー手術やインプラント部位の周囲のフラップを閉じる際に使用が増加
    • 歯周創傷治癒と再生を促進する歯周外科手術用の代替生体材料
    • 歯科手術の需要増加
  • 抑制要因
    • フィブリンシーラントの高コスト
  • 機会
    • 政府資金の増加とヘルスケアの質の向上
    • 増加する外科手術に対応する技術の進歩
  • 課題
    • アレルギー反応の兆候
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 フィブリンシーラント市場：製品別

• 液体形態
• パッチ

第7章 フィブリンシーラント市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門クリニック

第8章 南北アメリカのフィブリンシーラント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のフィブリンシーラント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのフィブリンシーラント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Baxter International Inc.
• Cryolife Inc.
• CSL Behring
• Ethicon LLC
• Haemcure Corporation
• Harvest Technologies Inc.
• Hualan Biological Engineering Inc.
• Johnson & Johnson Services, inc
• Mallinckrodt Pharmaceuticals
• Medicines Company
• Omrix Biopharmaceutical Inc.
• Shanghai Raas Blood Products Co. Ltd
• The Takeda Pharmaceutical Company Limited
• Vivostat A/S
• Zimmer Biomet

LIST OF FIGURES

• FIGURE 1. FIBRIN SEALANT MARKET RESEARCH PROCESS
• FIGURE 2. FIBRIN SEALANT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL FIBRIN SEALANT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL FIBRIN SEALANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. FIBRIN SEALANT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. FIBRIN SEALANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. FIBRIN SEALANT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL FIBRIN SEALANT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL FIBRIN SEALANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. FIBRIN SEALANT MARKET DYNAMICS
• TABLE 7. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL FIBRIN SEALANT MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL FIBRIN SEALANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL FIBRIN SEALANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL FIBRIN SEALANT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. CANADA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CHINA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. INDIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ITALY FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. POLAND FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. QATAR FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. FIBRIN SEALANT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. FIBRIN SEALANT MARKET, FPNV POSITIONING MATRIX, 2023

The Fibrin Sealant Market was valued at USD 391.16 million in 2023, expected to reach USD 445.89 million in 2024, and is projected to grow at a CAGR of 14.08%, to USD 984.02 million by 2030.

Fibrin sealants, composed mainly of fibrinogen and thrombin, serve as hemostatic agents used to control bleeding and aid tissue sealing during surgical procedures. The scope of fibrin sealant usage extends across a variety of medical departments, including cardiovascular, orthopedic, and neurosurgical applications, enhancing wound healing and reducing postoperative complications. These sealants are crucial where conventional methods of hemostasis, such as sutures or cauterization, are insufficient, making their application indispensable in complex surgeries. The end-use scope is broad, ranging from hospitals and ambulatory surgical centers to specialized clinics. Growth factors driving the fibrin sealant market include the increasing incidence of surgeries worldwide, advancements in surgical techniques, and the growing demand for minimally invasive procedures that require effective bleeding control. There's also a rising emphasis on reducing surgery-associated risks, propelling the demand for effective hemostatic agents. Opportunities in this market lie in the development of cost-effective sealants with enhanced protein purity and biocompatibility, catering to both established and emerging markets. Additionally, tailored formulations for specific surgical needs, and the deployment of innovative delivery systems, such as sprays or new applicator designs, offer potential growth avenues. However, limitations persist, primarily due to the high costs of fibrin sealants and the potential for side effects or periodical immunogenic reactions. Stringent regulatory landscapes across different regions also pose challenges, alongside the risk of viral transmission from plasma-derived components. To foster growth, investing in research that focuses on developing synthetic or recombinant fibrin formulations can be promising, particularly those aiming at reducing dependence on donor-derived products, which can mitigate viral risks. The nature of the market is competitive yet ripe for innovation, with continuous research and collaboration among biotech firms and surgical teams pivotal in driving forward novel developments and expanding market reach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fibrin Sealant Market

The Fibrin Sealant Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing use in microsurgical procedures and closing flaps around implant site
  • Alternative biomaterial for periodontal surgery stimulating periodontal wound healing and regeneration
  • Growing demand for dental surgeries
• Market Restraints
  • High cost of fibrin sealants
• Market Opportunities
  • Increase in government funding and improvement in the quality of healthcare
  • Advancements in technology to meet increasing surgical procedures
• Market Challenges
  • Signs of an allergic reaction

Porter's Five Forces: A Strategic Tool for Navigating the Fibrin Sealant Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fibrin Sealant Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fibrin Sealant Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fibrin Sealant Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fibrin Sealant Market

A detailed market share analysis in the Fibrin Sealant Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fibrin Sealant Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fibrin Sealant Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fibrin Sealant Market

A strategic analysis of the Fibrin Sealant Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fibrin Sealant Market, highlighting leading vendors and their innovative profiles. These include Baxter International Inc., Cryolife Inc., CSL Behring, Ethicon LLC, Haemcure Corporation, Harvest Technologies Inc., Hualan Biological Engineering Inc., Johnson & Johnson Services, inc, Mallinckrodt Pharmaceuticals, Medicines Company, Omrix Biopharmaceutical Inc., Shanghai Raas Blood Products Co. Ltd, The Takeda Pharmaceutical Company Limited, Vivostat A/S, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Fibrin Sealant Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Liquid Form and Patch.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use in microsurgical procedures and closing flaps around implant site
    • 5.1.1.2. Alternative biomaterial for periodontal surgery stimulating periodontal wound healing and regeneration
    • 5.1.1.3. Growing demand for dental surgeries
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of fibrin sealants
  • 5.1.3. Opportunities
    • 5.1.3.1. Increase in government funding and improvement in the quality of healthcare
    • 5.1.3.2. Advancements in technology to meet increasing surgical procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Signs of an allergic reaction
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Fibrin Sealant Market, by Product

• 6.1. Introduction
• 6.2. Liquid Form
• 6.3. Patch

7. Fibrin Sealant Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals
• 7.4. Specialty Clinics

8. Americas Fibrin Sealant Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Fibrin Sealant Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Fibrin Sealant Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Baxter International Inc.
• 2. Cryolife Inc.
• 3. CSL Behring
• 4. Ethicon LLC
• 5. Haemcure Corporation
• 6. Harvest Technologies Inc.
• 7. Hualan Biological Engineering Inc.
• 8. Johnson & Johnson Services, inc
• 9. Mallinckrodt Pharmaceuticals
• 10. Medicines Company
• 11. Omrix Biopharmaceutical Inc.
• 12. Shanghai Raas Blood Products Co. Ltd
• 13. The Takeda Pharmaceutical Company Limited
• 14. Vivostat A/S
• 15. Zimmer Biomet